Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma
Clive S. Zent, Michael T. Brady, Carolyne Delage, Myla Strawderman, Nathan Laniewski, Phuong N. Contant, Preshetha Kanagaiah, Mark Y. Sangster, Paul M. Barr, Charles C. Chu, David J. Topham, Jonathan W. Friedberg
Topics & Concepts
Lymphoplasmacytic LymphomaMedicineLymphomaBruton's tyrosine kinaseImmunologyVaccinationVirologyCancer researchInternal medicineWaldenstrom macroglobulinemiaTyrosine kinaseReceptorChronic Lymphocytic Leukemia ResearchViral-associated cancers and disordersLymphoma Diagnosis and Treatment